E-notebook enterprise oracle support software licenses
Ended Purchase Order Awarded Last action
- Contract number
- 75N95022P00195
- Awardee
-
Revvity Signals Software, Inc. UEI YJRFVQ6WNJV7 Part of Revvity Inc.
- Awarding agency
-
National Institute on Drug Abuse
National Institutes of Health, Department of Health and Human Services
- Obligated
- $57,000
Award facts
- Opportunity
-
- Annual Subscription and Bronze Support for E-Notebook Enterprise Oracle Pro Special Notice · 75N95022R00040 · Posted Mar 8, 2022
- Contract value 48% obligated
-
- $57,000.00 Current, with exercised options
- $119,920.00 Potential, with all options
- Completion date 100% complete
-
- Current, with exercised options
- Potential, with all options
- Funding agency
- National Center for Advancing Translational Sciences National Institutes of Health, Department of Health and Human Services
- NAICS code
- 541511 Custom Computer Programming Services
- PSC
- R499 Support- Professional: Other
- Set-aside
- No set-aside
- Competition
- Not Competed · 1 offer Only One Source
- Pricing
- Firm Fixed Price
- Place of performance
- Bethesda, MD 20892, USA
- Legislative mandates
-
- Clinger-Cohen Act FAR part 39
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Supplemental Agreement for work within scope | $29,200 | |
| Original award | $27,800 |
About this award
The Department of Health and Human Services National Institutes of Health National Center for Advancing Translational Sciences awarded a firm fixed-price purchase order to Revvity Signals Software, Inc. Informatics Division, a subsidiary of Revvity Inc. Medical Imaging, LLC, for an annual subscription and bronze support for E-Notebook Enterprise Oracle Pro software. The potential value of the contract is $119,920.00 over a period from March 26, 2022 to March 25, 2026. This software will be used by chemists within the National Center for Advancing Translational Sciences to capture their experiments and support their research. The contract does not have a set-aside designation.
Quick answers
Who was awarded contract 75N95022P00195?
75N95022P00195 was awarded to Revvity Signals Software, Inc. by National Institute on Drug Abuse (National Institutes of Health) on March 26, 2022.
How much is contract 75N95022P00195 worth?
The government has obligated $57,000 on 75N95022P00195. Its potential value, with all options, is $119,920.
Which agency awarded contract 75N95022P00195?
National Institute on Drug Abuse (National Institutes of Health) awarded 75N95022P00195, with funding from National Center for Advancing Translational Sciences (National Institutes of Health).
Was contract 75N95022P00195 competed?
The extent of competition for 75N95022P00195 was not competed. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award